Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy

Fig. 3

Lipase mass concentration during coadministration of three drugs in group 2. a  LPL mass concentration. b  EL mass concentration. White indicates the baseline. Blue indicates the second blood sampling when rosuvastatin at 10 mg/day and ezetimibe at 10 mg/day were coadministered. Pink indicates the third blood sampling when rosuvastatin at 20 mg/day and ezetimibe at 10 mg/day were coadministered. Purple indicates the last blood sampling when rosuvastatin at 20 mg/day, ezetimibe at 10 mg/day, and colestimide at 3.62 g/day were coadministered

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X